Showing results (1931-1940 of 1,995) with videos related to

Sort By:
Pageof 200
NPJ Precision Oncology|February 6, 2026
Adipocyte-driven STAT3-ANGPT2-PTGIS axis promotes cutaneous metastasis in breast cancer and represents a targetable pathwayChi-Wen Luo, Fu Ou-Yang, Shu-Jyuan Chang, et al.
Plos One|November 3, 2017
Multi-center study on patient selection for and the oncologic safety of intraoperative radiotherapy (IORT) with the Xoft Axxent® eBx® System for the management of early stage breast cancer in TaiwanHung-Wen Lai, Liang-Chih Liu, Fu Ouyang, et al.
Journal of the American Chemical Society|June 2, 2021
Quantifying Photoinduced Polaronic Distortions in Inorganic Lead Halide Perovskite NanocrystalsOliviero Cannelli, Nicola Colonna, Michele Puppin, et al.
Computer Methods and Programs in Biomedicine|February 20, 2025
Deep-learning-based diagnosis framework for ankle-brachial index defined peripheral arterial disease of lower extremity wound: Comparison with physiciansMing-Feng Tsai, Yu-Chang Chu, Wen-Teng Yao, et al.
Cancer Genomics & Proteomics|January 2, 2026
Comparative Transcriptomic Analysis Identifies Predictive Biomarkers of Pathological Complete Response in Triple-negative Breast CancerFang-Ming Chen, Chung-Liang Li, Mei-Ren Pan, et al.
Cell Death and Differentiation|November 17, 2022
ARID2 mitigates hepatic steatosis via promoting the ubiquitination of JAK2Hui-Jun Cao, Hao Jiang, Kai Ding, et al.
Journal of Clinical Medicine|October 27, 2022
Efficacy of Dupilumab on Different Phenotypes of Adult with Moderate-to-Severe Atopic Dermatitis in Taiwan: A Real-World StudyChin-Yi Yang, Po-Ju Lai, Chun-Bing Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2007
Targeted deletion of fgl2 leads to impaired regulatory T cell activity and development of autoimmune glomerulonephritisItay Shalev, Hao Liu, Cheryl Koscik, et al.
Journal for Immunotherapy of Cancer|July 29, 2020
Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 in patients with metastatic breast cancer: phase II randomized, placebo-controlled studyChiun-Sheng Huang, Alice L Yu, Ling-Ming Tseng, et al.
Oncology Research and Treatment|July 21, 2024
Comparison of the Efficacy, Safety, and Quality of Life of Pegylated Liposomal Doxorubicin-Cyclophosphamide versus Epirubicin-Cyclophosphamide in Patients with Early-Stage HER2-Negative Breast Cancer: A Prospective, Randomized, Multicenter, Phase II StudyLing-Ming Tseng, Fang Ming Chen, Shou-Tung Chen, et al.
Pageof 200